Latest News
Most logo advice online assumes you have either a big budget or a designer on call. The reality for most founders, freelancers, and small business owners is neither. AI logo generators have changed what is actually possible on a tight timeline and a tight budget. The best ones today do not just hand you a [...]
Via Visibility · June 23, 2026
Here's why I think BCE is a TSX dividend stock that could outpace TELUS over the next 12 months and beyond.
Via The Motley Fool · June 23, 2026
Suncor Energy (TSX:SU) looks like a great bet for TFSA investors looking for value and dividends.
Via The Motley Fool · June 23, 2026
Formerly winning stocks have slipped in recent days.
Via The Motley Fool · June 23, 2026
Santander AML Compliance Framework: 311K+ Suspicious Activity Reports The group's Chilean unit (NYSE: BSAC) operates under a demanding financial-crime compliance framework that combines Chilean regulatory oversight with SEC disclosure obligations linked to its U.S.-listed ADR program. Grupo Santander, one of the world's largest banking groups, filed over 311,000 suspicious activity reports (SARs) across its global operations [...]
Via Visibility · June 22, 2026
Investors can now buy SpaceX shares at the same price as on its IPO day. Should they?
Via The Motley Fool · June 23, 2026
SpaceX's revenue is set to double by the end of the year thanks to a booming data center business.
Via The Motley Fool · June 23, 2026
This Canadian stock offers a 5% yield and has a solid history of consistent cash payments for decades, making it a reliable dividend payer.
Via The Motley Fool · June 23, 2026
Low-risk stocks are back in vogue.
Via The Motley Fool · June 23, 2026
Canadians should aim to maximize their TFSA and grow savings through consistent investing.
Via The Motley Fool · June 23, 2026
SpaceX has numerous ambitions in the artificial intelligence arena, but should retail investors favor it over the GPU giant?
Via The Motley Fool · June 23, 2026
These defensive Canadian stocks could support patient TFSA compounding.
Via The Motley Fool · June 23, 2026
How landlords can screen tenants to cut risk while staying within Fair Housing rules.
Via The Motley Fool · June 23, 2026
Congress needs to find a solution before the issue becomes dire.
Via The Motley Fool · June 23, 2026
Investors can ease any rate-related concerns by buying and seeking comfort in two Canadian dividend giants.
Via The Motley Fool · June 23, 2026
A tentative peace deal could mean much-needed relief for some companies, and the government shuts down Anthropic’s Fable 5.
Via The Motley Fool · June 23, 2026
Verizon's 22-year run in the iconic Dow is ending, with a trillion-dollar company that's an artificial intelligence (AI) applications leader taking its place.
Via The Motley Fool · June 23, 2026
Celestica has already surged nearly 200%, but its role in building the physical backbone of AI data centres still looks powerful.
Via The Motley Fool · June 23, 2026
An analyst reiterated his very sunny outlook on the CRM king's future.
Via The Motley Fool · June 23, 2026
Tìm hiểu HitClub để cập nhật các thông tin mới nhất về hệ thống, những cải tiến trong giao diện và các nội dung đang được quan tâm. Nền tảng liên tục bổ su
Via Talk Markets · June 23, 2026
Tipping used to be fairly straightforward. You tipped restaurant servers, delivery drivers and a handful of other service workers. Today, consumers are increasingly being asked to leave gratuities everywhere from coffee
Via Benzinga · June 23, 2026
Given their solid underlying businesses, reliable cash flows, healthy growth prospects, and high yields, these three TSX stocks could be ideal for income-seeking investors.
Via The Motley Fool · June 23, 2026
This Canadian ETF offers instant exposure to some of the best stocks in Canada, making it a simple long-term buy-and-hold option.
Via The Motley Fool · June 23, 2026
This LiDAR-on-chip innovator for automation and safety solutions reported a notable insider sale amid ongoing shifts in executive holdings.
Via The Motley Fool · June 23, 2026
Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate industry headwinds.
Via The Motley Fool · June 23, 2026